Revance Therapeutics (RVNC) Profit Margin (2014 - 2024)
Revance Therapeutics (RVNC) profit margin from Mar 31, 2014 to Sep 30, 2024. The current Revance Therapeutics (RVNC) profit margin is -63.64%. You can export chart.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Revance Therapeutics (RVNC)
| Year | Profit Margin | Change |
|---|---|---|
| 2023 | -138.43% | -48.51% |
| 2022 | -268.85% | -25.64% |
| 2021 | -361.58% | -80.35% |
| 2020 | -1840.12% | -95.27% |
| 2019 | -38885.37% | +917.34% |
| 2018 | -3822.25% | -91.76% |
| 2017 | -46380.77% | +55.87% |
| 2016 | -29756.67% | +21.49% |
| 2015 | -24493.33% | +47.93% |
| 2014 | -16557.89% | N/A |
Comparison Revance Therapeutics (RVNC) profit margin with competitors
Revance Therapeutics (RVNC) profit margin is -63.64%.